Defilade Capital Management, L.P. Quant / Systematic

Location: Emeryville, CA

CIK: 0002088557 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $747M (100.0% shares, 0.0% debt)

Holdings (39)

LLY ELI LILLY & CO 6.3%
Value $46.88M Shares 39,086 Est. Cost Unrealized
PFE PFIZER INC 5.7%
Value $42.66M Shares 1,771,743 Est. Cost Unrealized
VEEV VEEVA SYS INC 5.6%
Value $42.01M Shares 236,709 Est. Cost Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 5.2%
Value $39.02M Shares 682,005 Est. Cost Unrealized
PTCT PTC THERAPEUTICS INC 4.7%
Value $35.38M Shares 433,699 Est. Cost Unrealized
BAX BAXTER INTL INC 4.2%
Value $31.11M Shares 1,459,380 Est. Cost Unrealized
INSM INSMED INC 4.0%
Value $30.05M Shares 281,838 Est. Cost Unrealized
ZBH ZIMMER BIOMET HOLDINGS INC 3.7%
Value $27.33M Shares 317,426 Est. Cost Unrealized
PODD INSULET CORP 3.6%
Value $26.94M Shares 176,932 Est. Cost Unrealized
TMO THERMO FISHER SCIENTIFIC INC 3.5%
Value $26.04M Shares 51,934 Est. Cost Unrealized
ABT ABBOTT LABORATORIES 3.5%
Value $25.93M Shares 285,778 Est. Cost Unrealized
ASND ASCENDIS PHARMA A/S 3.4%
Value $25.3M Shares 94,843 Est. Cost Unrealized
SOLV SOLVENTUM CORP 3.3%
Value $24.41M Shares 316,454 Est. Cost Unrealized
MDT MEDTRONIC PLC 3.2%
Value $23.73M Shares 303,301 Est. Cost Unrealized
ELAN ELANCO ANIMAL HEALTH INC 2.8%
Value $21.27M Shares 864,080 Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 2.7%
Value $20.29M Shares 546,848 Est. Cost Unrealized
NVST ENVISTA HOLDINGS CORPORATION 2.6%
Value $19.13M Shares 726,108 Est. Cost Unrealized
RVMD REVOLUTION MEDICINES INC 2.1%
Value $15.51M Shares 82,827 Est. Cost Unrealized
ICUI ICU MED INC 2.1%
Value $15.5M Shares 105,700 Est. Cost Unrealized
COGT COGENT BIOSCIENCES INC 2.0%
Value $15.23M Shares 393,441 Est. Cost Unrealized
LNTH LANTHEUS HLDGS INC 2.0%
Value $14.72M Shares 132,662 Est. Cost Unrealized
OCUL OCULAR THERAPEUTIX INC 2.0%
Value $14.63M Shares 1,490,286 Est. Cost Unrealized
ELDN ELEDON PHARMACEUTICALS INC 1.9%
Value $13.89M Shares 3,525,338 Est. Cost Unrealized
TYRA TYRA BIOSCIENCES INC 1.6%
Value $12.04M Shares 376,870 Est. Cost Unrealized
OLMA OLEMA PHARMACEUTICALS INC 1.5%
Value $11.57M Shares 924,758 Est. Cost Unrealized
ORIC ORIC PHARMACEUTICALS INC 1.5%
Value $11.35M Shares 1,047,690 Est. Cost Unrealized
LRMR LARIMAR THERAPEUTICS INC 1.5%
Value $11.19M Shares 3,670,135 Est. Cost Unrealized
GMED GLOBUS MED INC 1.5%
Value $11.03M Shares 139,637 Est. Cost Unrealized
ENOV ENOVIS CORPORATION 1.5%
Value $11.01M Shares 531,945 Est. Cost Unrealized
EVMN EVOMMUNE INC 1.4%
Value $10.54M Shares 793,145 Est. Cost Unrealized
TFX TELEFLEX INCORPORATED 1.4%
Value $10.16M Shares 80,118 Est. Cost Unrealized
DNLI DENALI THERAPEUTICS INC 1.3%
Value $10.08M Shares 391,866 Est. Cost Unrealized
GKOS GLAUKOS CORP 1.2%
Value $9.297M Shares 66,519 Est. Cost Unrealized
STAA STAAR SURGICAL CO 1.2%
Value $9.242M Shares 322,126 Est. Cost Unrealized
PACS PACS GROUP INC 1.2%
Value $9.196M Shares 215,675 Est. Cost Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.2%
Value $8.96M Shares 239,440 Est. Cost Unrealized
LIVN LIVANOVA PLC 1.2%
Value $8.829M Shares 107,373 Est. Cost Unrealized
BDTX BLACK DIAMOND THERAPEUTICS I 0.4%
Value $3.099M Shares 1,674,999 Est. Cost Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.3%
Value $2.401M Shares 7,558,756 Est. Cost Unrealized